日本語フィールド
著者：Verissimo A.R, Nakayama K.題名：Scaffold-Free Biofabrication発表情報：LIVE 3D Printing and Biofabrication ページ: 1-20キーワード：概要：抄録：Abstract
Tissue engineering and regenerative medicine have met great scientific, medical, and technological advances in the past decade. Most methods combine scaffolds, such as polymers, and living cells to make implantable structures that will integrate and heal the host’s tissues. More recently, alternative scaffold-free approaches have started to emerge. This chapter provides an overview of the current scaffold-free systems, advantages, challenges, methods, and applications. Scaffold-free tissue artificially produced in the lab using patients’ own cells has already been successfully used in heart and blood vessel regeneration at a small scale. New techniques and approaches are being developed, not only in terms of assembling cells and structures but also in terms of new equipment, namely for 3D bioprinting. Both primary and stem or iPSC-derived cells are used to assemble artificial tissues that are currently being tested in vivo and in vitro. These engineered constructs have numerous applications, such as regenerative medicine, disease models, and drug testing.英語フィールド
Author：Verissimo A.R, Nakayama K.Title：Scaffold-Free BiofabricationAnnouncement information:LIVE 3D Printing and Biofabrication Page: 1-20An abstract：Abstract
Tissue engineering and regenerative medicine have met great scientific, medical, and technological advances in the past decade. Most methods combine scaffolds, such as polymers, and living cells to make implantable structures that will integrate and heal the host’s tissues. More recently, alternative scaffold-free approaches have started to emerge. This chapter provides an overview of the current scaffold-free systems, advantages, challenges, methods, and applications. Scaffold-free tissue artificially produced in the lab using patients’ own cells has already been successfully used in heart and blood vessel regeneration at a small scale. New techniques and approaches are being developed, not only in terms of assembling cells and structures but also in terms of new equipment, namely for 3D bioprinting. Both primary and stem or iPSC-derived cells are used to assemble artificial tissues that are currently being tested in vivo and in vitro. These engineered constructs have numerous applications, such as regenerative medicine, disease models, and drug testing.